IMMUNOME INC (IMNM) Stock Income Statement
NASDAQ:IMNM • US45257U1088
Current stock price
24.54 USD
+1.28 (+5.5%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.94M | 9.04M | 14.02M | 0.00 | 0.00 | |||
| Operating Expenses | 221.05M | 162.50M | 42.75M | 36.90M | 25.20M | |||
| Research and Development | 177.29M | 129.54M | 22.93M | 23.11M | 14.11M | |||
| Selling, General, and Administrative Expenses | 43.77M | 32.95M | 19.82M | 13.79M | 11.09M | |||
| Operating Income | -214.11M | -153.46M | -28.73M | -36.90M | -25.20M | |||
| Interest Income/Expense | 11.72M | 12.84M | 2.72M | 10.00K | -10.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 500.00K | |||
| Non Recurring Items | -10.00M | -152.34M | -80.80M | N/A | N/A | |||
| Income Before Taxes | -212.39M | -292.96M | -106.81M | -36.90M | -24.71M | |||
| Net Income | -212.39M | -292.96M | -106.81M | -37.52M | -24.71M | |||
| EBITDA | -211.65M | -151.89M | -28.27M | -36.48M | -24.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.43 | -5.00 | -5.38 | -3.09 | -2.14 | |||
| Non GAAP EPS | -2.43 | -5.17 | N/A | -3.09 | -2.16 | |||
| Statistics | ||||||||
| Profit Margin | -3059.99% | -3240.38% | -761.92% | N/A | N/A | |||
| Operating Profit Margin | -3084.76% | -1697.33% | -204.94% | N/A | N/A | |||
All data in USD